HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Horowitz Selected Research

Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)

12/2012Final infarct volume is a stronger predictor of outcome than recanalization in patients with proximal middle cerebral artery occlusion treated with endovascular therapy.
6/2010Comparison of safety and clinical and radiographic outcomes in endovascular acute stroke therapy for proximal middle cerebral artery occlusion with intubation and general anesthesia versus the nonintubated state.
9/2004Successful management of post-tumor resection middle cerebral artery thrombosis with stent-assisted angioplasty and thrombolytic therapy: case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Horowitz Research Topics

Disease

113Type 2 Diabetes Mellitus (MODY)
05/2024 - 08/2002
40Critical Illness (Critically Ill)
05/2023 - 01/2006
26Obesity
12/2023 - 08/2002
19Hypotension (Low Blood Pressure)
08/2021 - 04/2002
18Hyperglycemia
01/2023 - 08/2003
14Aneurysm (Aneurysms)
11/2021 - 07/2003
13Diabetes Mellitus
06/2022 - 03/2002
13Nausea
01/2021 - 02/2003
12Weight Loss (Weight Reduction)
03/2024 - 11/2003
12Hypoglycemia (Reactive Hypoglycemia)
01/2023 - 10/2003
12Gastroparesis
12/2019 - 01/2002
10Insulin Resistance
04/2024 - 03/2008
10Body Weight (Weight, Body)
03/2021 - 04/2004
10Malnutrition (Nutritional Deficiencies)
11/2018 - 08/2003
9Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2024 - 02/2004
8Glucose Intolerance
09/2022 - 10/2008
7Neoplasms (Cancer)
05/2024 - 08/2002
7Overweight
01/2021 - 06/2009
7Hemifacial Spasm
06/2017 - 10/2011
6Stroke (Strokes)
12/2012 - 01/2005
6Thrombosis (Thrombus)
05/2012 - 09/2004
5Osteoporosis
07/2009 - 01/2004
4Intracranial Aneurysm (Cerebral Aneurysm)
11/2021 - 05/2004
4Morbid Obesity
10/2019 - 01/2006
4Cystic Fibrosis (Mucoviscidosis)
01/2019 - 05/2011
4Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
01/2014 - 10/2008
4Hemorrhage
07/2011 - 11/2003
4Vitamin D Deficiency
11/2008 - 05/2007
3Dyspepsia (Indigestion)
02/2024 - 06/2007
3Pain (Aches)
02/2024 - 10/2004
3Vomiting
01/2021 - 02/2003
3Weight Gain
10/2019 - 02/2013
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2012 - 09/2004
3Diarrhea
06/2012 - 02/2003
3Bone Resorption
07/2009 - 07/2004
2Psoriasis (Pustulosis Palmaris et Plantaris)
05/2024 - 02/2024
2Pancreatic Neoplasms (Pancreatic Cancer)
05/2024 - 02/2024
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2024 - 02/2024
2Basal Cell Carcinoma (Rodent Ulcer)
05/2024 - 02/2024
2Diabetes Complications
12/2023 - 03/2002
2Anorexia
01/2022 - 08/2003

Drug/Important Bio-Agent (IBA)

109Glucose (Dextrose)FDA LinkGeneric
05/2024 - 01/2002
50Glucagon-Like Peptide 1 (GLP 1)IBA
04/2024 - 08/2002
46Blood Glucose (Blood Sugar)IBA
05/2023 - 08/2002
44Insulin (Novolin)FDA Link
05/2024 - 08/2002
28IncretinsIBA
01/2022 - 08/2002
25Hormones (Hormone)IBA
01/2022 - 08/2002
21Proteins (Proteins, Gene)FDA Link
01/2023 - 09/2009
17CarbohydratesIBA
05/2024 - 08/2002
16Glucagon (Glukagon)FDA Link
11/2023 - 01/2009
14Metformin (Glucophage)FDA LinkGeneric
04/2024 - 08/2014
12Whey ProteinsIBA
01/2023 - 09/2009
10Peptides (Polypeptides)IBA
03/2024 - 08/2002
9lixisenatideIBA
06/2022 - 02/2013
8Exenatide (Byetta)FDA Link
01/2021 - 11/2008
8CalciumIBA
07/2009 - 01/2004
7LipidsIBA
01/2016 - 03/2006
6Biomarkers (Surrogate Marker)IBA
05/2024 - 05/2004
6Glucagon-Like Peptide-1 Receptor AgonistsIBA
05/2023 - 05/2006
6Glucagon-Like Peptide-1 ReceptorIBA
11/2021 - 08/2013
6Cholecystokinin (Pancreozymin)IBA
08/2013 - 01/2006
5Bile Acids and Salts (Bile Acids)IBA
01/2022 - 04/2013
5Peptide YYIBA
12/2018 - 01/2006
5GhrelinIBA
12/2018 - 08/2003
5Dipeptidyl-Peptidase IV InhibitorsIBA
12/2016 - 06/2009
4AntralIBA
02/2024 - 06/2007
4AcidsIBA
11/2022 - 05/2004
4Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA
03/2021 - 08/2012
4Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2021 - 03/2002
4VildagliptinIBA
01/2020 - 04/2016
4Vitamin DFDA LinkGeneric
11/2008 - 05/2007
3Keratin-17 (Keratin 17)IBA
05/2024 - 02/2024
3EnzymesIBA
11/2023 - 05/2011
3Dietary ProteinsIBA
01/2023 - 07/2022
3Sitagliptin Phosphate (Januvia)FDA Link
01/2020 - 07/2013
3guar gum (guaran)IBA
12/2019 - 07/2003
3Sweetening Agents (Sweeteners)IBA
10/2019 - 06/2011
3Erythromycin (Erycette)FDA LinkGeneric
06/2013 - 01/2010
3Botulinum Toxins (Botulinum Toxin)IBA
06/2013 - 10/2011
3Hypoglycemic Agents (Hypoglycemics)IBA
06/2009 - 02/2003
3hydroxide ionIBA
11/2008 - 04/2004
325-hydroxyvitamin DIBA
10/2008 - 06/2005
3Parathyroid Hormone (Parathormone)IBA
10/2008 - 04/2004
3XenonIBA
01/2008 - 01/2005
2Plant Preparations (Preparation, Plant)IBA
02/2024 - 06/2007
2Dietary Fats (Dietary Fat)IBA
01/2022 - 09/2007
2semaglutideIBA
10/2021 - 01/2021

Therapy/Procedure

38Therapeutics
05/2024 - 08/2003
19Glycemic Control
09/2023 - 03/2002
14Enteral Nutrition (Feeding, Tube)
01/2022 - 05/2008
11Stents
01/2012 - 11/2003
8Microvascular Decompression Surgery
06/2017 - 04/2002
6Catheters
09/2012 - 08/2005
4Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2017 - 01/2006
4Intravenous Infusions
06/2015 - 02/2006
3Drug Therapy (Chemotherapy)
04/2024 - 06/2013
3Bariatric Surgery
12/2023 - 01/2017
3Aftercare (After-Treatment)
01/2021 - 11/2005
2Neoadjuvant Therapy
05/2024 - 02/2024
2Cholecystectomy
01/2022 - 06/2006